Phase II Trial of Daily Dose of Oral Vaccine Against Atherosclerosis

Trial Profile

Phase II Trial of Daily Dose of Oral Vaccine Against Atherosclerosis

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2018

At a glance

  • Drugs Atherosclerosis vaccine (Primary)
  • Indications Atherosclerosis
  • Focus Pharmacodynamics; Registrational
  • Sponsors Immunitor
  • Most Recent Events

    • 16 Aug 2018 Planned End Date changed from 18 May 2018 to 18 Dec 2018.
    • 16 Aug 2018 Planned primary completion date changed from 18 Feb 2018 to 18 Dec 2018.
    • 27 Mar 2017 Status changed from active, no longer recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top